ALGS insider transaction filings
Aligos Therapeutics, Inc. — 22 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-29. Screen ALGS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Chavez Margarita — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Hirth Peter — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Nuechterlein Carole — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Martell Bridget A — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Preston Heather — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Scopa James Paul — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Symons Julian A. — See Remarks | Grant/award (A): 23,310 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Aneja Nikhil — Principal Accounting Officer | Grant/award (A): 9,450 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Calhoun Lesley Ann — See Remarks | Grant/award (A): 37,485 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | BLATT LAWRENCE — President and CEO, Director | Grant/award (A): 105,840 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Symons Julian A. — See Remarks | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Calhoun Lesley Ann — See Remarks | Grant/award (A): 40,185 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | BLATT LAWRENCE — President and CEO, Director | Grant/award (A): 179,800 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Hirth Peter — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Chavez Margarita — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Nuechterlein Carole — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Martell Bridget A — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Preston Heather — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Scopa James Paul — Director | Grant/award (A): 5,860 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Symons Julian A. — See Remarks | Grant/award (A): 21,693 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Calhoun Lesley Ann — See Remarks | Grant/award (A): 47,271 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | BLATT LAWRENCE — President and CEO, Director | Grant/award (A): 140,103 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aligos Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-04-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALGS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →